Skip to content
AnalystLens
Back to ROIVBalance Sheet

Roivant Sciences Shares Outstanding 2021-2027 | ROIV

Annual FY2021–FY2026 · quarterly through Q1 FY2027

Latest annual · FY2026

720.4M

+3.5%YoY vs FY2025Source: 10-KFY2026

From 651.6M in FY2021 to 720.4M in FY2026: 1.1× in 5 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY27723M+5.9%Not reportedNot reportedNot reported
FY26682M−7.7%690M−5.9%710M−1.4%720M+3.5%
FY25739M−3.7%733M−8.4%720M−10.6%696M−13.7%
FY24767M+9.4%801M+13.7%805M+10.7%807M+6.1%
FY23701M+214.9%704M+2.9%727M+5.0%760M+9.4%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date.

Key Statistics

Trend DirectionStable
CAGR

+2.0%

FY2021
651.6M
FY2026
720.4M

5 years selected · on the chart

Shares Outstanding History

Year-over-year comparison from 10-K annual reports

  1. 720.4M
YoY changeLargest recent move−13.7%in FY25Latest +3.5%

Shares Outstanding, period by period

PeriodValueChangeSource
FY2026720.4M+3.5%10-K
FY2025695.9M−13.7%10-K
FY2024806.7M+6.1%10-K
FY2023760.1M+9.4%10-K
FY2022695.0M+6.7%10-K
FY2021651.6M—10-K

What is shares outstanding?

Shares outstanding is the total number of common shares currently held by all shareholders, including restricted shares.

What is Roivant Sciences's current shares outstanding?

Roivant Sciences (ROIV) annual shares outstanding for 2026 was 720.4M, a 3.51% increase from 2025. Roivant Sciences shares outstanding for the quarter ending June 30, 2026 was 722.7M.

What was Roivant Sciences's shares outstanding in 2025?

Roivant Sciences annual shares outstanding for 2025 was 695.9M, a 13.73% decline from 2024.

What was Roivant Sciences's shares outstanding in 2024?

Roivant Sciences annual shares outstanding for 2024 was 806.7M, a 6.12% increase from 2023.

What is Roivant Sciences's 5-year shares outstanding CAGR?

Roivant Sciences shares outstanding grew at a compound annual growth rate (CAGR) of 2.03% from FY2021 to FY2026, going from 651.6M to 720.4M over 5 years.

Company
Roivant Sciences
Ticker
ROIV
Sector
Healthcare
Industry
Pharmaceutical Preparations